Banque Cantonale Vaudoise’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-6,569
Closed -$1.08M 1390
2021
Q2
$1.08M Buy
6,569
+3,202
+95% +$535K 0.05% 408
2021
Q1
$516K Sell
3,367
-691
-17% -$93.8K 0.03% 535
2020
Q4
$509K Buy
4,058
+528
+15% +$59K 0.03% 491
2020
Q3
$358K Buy
3,530
+43
+1% +$4.38K 0.02% 529
2020
Q2
$339K Buy
3,487
+335
+11% +$31.2K 0.02% 509
2020
Q1
$262K Sell
3,152
-305
-9% -$29.7K 0.02% 555
2019
Q4
$384K Buy
+3,457
New +$356K 0.03% 550

Other funds holding PRAH

Banque Cantonale Vaudoise's PRAH Position: Q3 2021 in Review

Banque Cantonale Vaudoise sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 6,569 shares — an estimated $1.08M sold.

Banque Cantonale Vaudoise first reported a position in PRAH in Q4 2019 and held it in 7 quarters. The position peaked at $1.08M in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

  • Banque Cantonale Vaudoise reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • Banque Cantonale Vaudoise sold 6,569 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $1.08M.
  • Banque Cantonale Vaudoise first reported a position in PRA Health Sciences, Inc. in Q4 2019 and held it in 7 quarters.
  • Banque Cantonale Vaudoise's PRA Health Sciences, Inc. position peaked at $1.08M in Q2 2021.
  • 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Banque Cantonale Vaudoise's 13F filing for Q3 2021, filed 29 Oct 2021.